In 2024, the forecasted immunization coverage for the third dose of the polio vaccine (Pol3) in France remains stable at 95% for children aged 1 year old. This consistency from 2024 through 2028 reflects a strong and robust vaccination program, maintaining the same high-level achievement as in 2023, which also recorded a 95% coverage. With no year-on-year variation observed in the data, the Compound Annual Growth Rate (CAGR) over the five-year forecast period is 0%, indicating no expected change in coverage.
Future trends to watch for include potential policy changes affecting healthcare funding and vaccine availability. Additionally, monitoring vaccine hesitancy and its impact on maintaining high immunization rates should also be a priority, as well as the integration of new vaccination technologies that could influence public health strategies.
